Portolan Capital Management - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 194 filers reported holding NEVRO CORP in Q4 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
Portolan Capital Management ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2018$1,801,000
-31.9%
31,605
-4.5%
0.18%
-34.1%
Q2 2018$2,644,000
-7.9%
33,106
-0.0%
0.27%
-14.0%
Q1 2018$2,870,000
+24.7%
33,109
-0.7%
0.31%
+24.6%
Q4 2017$2,301,000
-54.8%
33,335
-40.5%
0.25%
-58.5%
Q3 2017$5,091,00056,0170.61%
Other shareholders
NEVRO CORP shareholders Q4 2017
NameSharesValueWeighting ↓
BRAIDWELL LP 1,192,298$47,215,0011.58%
Altium Capital Management LP 76,000$3,009,6001.53%
Rock Springs Capital Management LP 1,077,900$42,684,8401.03%
Integral Health Asset Management, LLC 109,000$4,316,4000.91%
ArrowMark Colorado Holdings LLC 1,252,218$49,587,8330.59%
FOX RUN MANAGEMENT, L.L.C. 26,963$1,067,7350.43%
PDT Partners, LLC 55,715$2,206,3140.36%
FRED ALGER MANAGEMENT, LLC 1,184,000$46,886,4000.25%
Dynamic Technology Lab Private Ltd 62,819$2,4880.25%
K2 PRINCIPAL FUND, L.P. 38,000$1,504,8000.23%
View complete list of NEVRO CORP shareholders